Arenas A, Ayala R, Gallardo M, et al. Ruxolitinib/nilotinib/prednisoline combination: a promising novel treatment for myelofibrosis. EHA 2017, abstract P695.,Arenas A, Ayala RM, Linares M, et al. Nilotinib plus ruxolitinib produces anti-fibrotic effect. Blood. 2016;128:5497.
THEMIS2-expressie verbetert voorspelling time-to-first-treatment bij CLL
jan 2024 | Leukemie